Hematology: Acute myeloid leukemia (aml) — High-intensity induction chemotherapy 1 cycle. Treatment
Acute myeloid leukemia is a malignant blood disorder, which can occur at any age. However, the elderly people are the most susceptible to it. The main treatment method for this disease is chemotherapy. Initial dose of the drugs prescribed immediately after the diagnosis is called the induction dose. The course is carried out in an intensive mode and allows achieving remission in 80-85% patients.
Early treatment is preceded by examination of the patient. The mandatory diagnostic program includes:
- oncologist’s advice,
- clinical examination,
- case history collection,
- complete blood count,
- blood chemistry,
- cytogenetic analysis.
The optimal drug intake regimen is developed based on the test findings.
The treatment is carried out in a hospital setting. The period of hospitalization in each case is determined individually. On average, one therapy unit lasts 14 days.
The aim of the induction treatment phase is to destroy cancer cells and restore the normal hematopoiesis. The drug is administered intravenously, and sometimes intrathecally (into the spinal canal). In order to achieve a rapid effect, a combination of several cytostatics is used. To reduce the side effects, the symptomatic therapy is administered simultaneously.
Throughout the treatment course, the patient is recommended:
- keep a diet,
- observe strict hygiene rules,
- minimize the contacts with other people.
1 chemotherapy unit depends on the cost of drugs and the length of stay in the clinic. During treatment, the patient receives nursing services in full.
Before discharge, the physician performs examination and gives recommendations for further treatment.Hide
Haven't found Your diagnosis yet?
Send an inquiry to get a cost estimate on: